Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metformin vs Topical Tranexamic Acid in Melasma
NCT07495748Not yet recruiting
- Sponsor
- Foundation University Islamabad
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of metformin 1% gel in melasma (2 arms), sponsored by Foundation University Islamabad. Primary endpoint: Melasma Area and Severity Index at 12 weeks. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
metformin 1% gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07495748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07495748.